Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group

Winfried Amoaku,1 Konstantinos Balaskas,2,3 Tomas Cudrnak,4 Louise Downey,5 Markus Groppe,6 Sajjad Mahmood,7 Hemal Mehta,8 Quresh Mohamed,9 Bushra Mushtaq,10 Philip Severn,11 Athanasios Vardarinos,12 Yit Yang,13 Saad Younis14 1Academic Ophthalmology, Division of Clinical Neuroscience, University of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Amoaku W, Balaskas K, Cudrnak T, Downey L, Groppe M, Mahmood S, Mehta H, Mohamed Q, Mushtaq B, Severn P, Vardarinos A, Yang Y, Younis S
Format:	article
Language:	EN
Published:	Dove Medical Press 2018
Subjects:	ranibizumab age-related macular degeneration nAMD treat and extend anti-VEGF treatment. Ophthalmology RE1-994
Online Access:	https://doaj.org/article/54ecb5ae5ee04cb69e3504e3f24862e9
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group

Similar Items